The Wound Care Collaborative Community is preparing to present the FDA with evidence to include parameters such as percent area reduction and percent volume reduction as acceptable primary endpoints in studies for the treatment of wounds.
The Wound Care Collaborative Community is preparing to present the FDA with evidence to include parameters such as percent area reduction and percent volume reduction as acceptable primary endpoints in studies for the treatment of wounds.
The Wound Care Collaborative...